Tsakos Energy Navigation Limited
TEN | NYSE
$51.58
-$2.27 (-4.22%)
Nov 2, 2026, 10:16 AM ET · Market open
Company Profile
Tsakos Energy Navigation Limited (TEN) is a global maritime company dedicated to the worldwide ocean transport of crude oil and refined petroleum products. The firm delivers vital shipping and logistics services to a wide array of clients, including national, major, and independent oil companies and refineries, utilizing a range of charter agreements that vary in duration from short-term to extensive long-term contracts. TEN boasts a modern, double-hulled fleet consisting of conventional tankers, liquefied natural gas (LNG) carriers, and specialized suezmax DP2 shuttle tankers. Established in 1993, the company operated under the name MIF Limited before officially adopting Tsakos Energy Navigation Limited in July 2001. Its central operations are managed from its headquarters situated in Athens, Greece.
Key Executives
| Name | Position |
|---|---|
| Nikolas Tsakos | Founder, CEO & Director |
| Clio Hatzimichalis | General Counsel & Director |
| George V. Saroglou | COO, President & Director |
| Michael Gordon Jolliffe | Co-Founder & Vice Chairman |
| Theo Harrys E. Kosmatos | CFO, Chief Accounting Officer & Corporate Development Officer |
| Vasileios Papageorgiou | Chief Marine Officer |
Tsakos Energy Navigation Limited
| Country | Greece |
| IPO Date | Mar 5, 2002 |
| Industry | Oil & Gas Midstream |
| Sector | Energy |
| Employees | 77 |
| CEO | Nikolas Tsakos |
Stock Details
| Ticker Symbol | TEN |
| Exchange | NYSE |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001166663 |
| CUSIP Number | G9108L173 |
| ISIN Number | BMG9108L1735 |
| SIC Code | 3714 |
Recent News
- 4 days ago / seekingalpha.comTsakos Energy Navigation: The Preferred Might Be A Better Pick Than The Common
- 7 days ago / globenewswire.comTEN, Ltd. Announces Common Shares Dividend and Share Repurchase Authorization
- 8 days ago / gurufocus.comRYBREVANT FASPRO™ (amivantamab and hyaluronidase-lpuj) combination demonstrates 77% overall response rate in first-line treatment of patients with advanced head and neck cancer
- 13 days ago / gurufocus.comSun Pharma Announces UNLOXCYT® (cosibelimab-ipdl) Has Received a Category 2A Preferred Designation in the Updated NCCN Guidelines for Locally Advanced Cutaneous Squamous Cell Carcinoma (laCSCC) Patien
- 26 days ago / businesswire.comTEN Hires Versatile Marketing Leader Daniel Incandela as Chief Marketing Officer
- 28 days ago / globenewswire.comTEN Ltd. Declares Dividend on its Series F Cumulative Redeemable Perpetual Preferred Shares
- 1 month ago / marketbeat.comTsakos Energy Navigation Highlights $3.6B Contract Backlog, Tanker Fleet Expansion
- 1 month ago / globenewswire.comTEN, Ltd. Continues Its Fleet Renewal and Reports Sale of Panamax Tanker
- 2 months ago / gurufocus.comRYBREVANT FASPRO™ (amivantamab and hyaluronidase-lpuj) plus LAZCLUZE® (lazertinib) with prophylactic strategies shows low rates of treatment-related events at WCLC 2026
- 2 months ago / gurufocus.comTAGRISSO® (osimertinib) demonstrated unprecedented eight-year landmark survival in early-stage EGFR-mutated lung cancer in ADAURA Phase III trial
Add to Watchlist
Select watchlists to add or remove TEN